What is the current valuation of the Gene Sequencing Market in 2025?

The Gene Sequencing Market is valued at approximately 24.7 USD Billion in 2024. Read More

What is the projected market size for the Gene Sequencing Market by 2035?

The market is expected to reach around 220.13 USD Billion by 2035. Read More

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The anticipated CAGR for the market is 22.0% from 2025 to 2035. Read More

Which technology segment is projected to dominate the market?

Next Generation Sequencing is projected to lead with a valuation of 80.0 USD Billion by 2035. Read More

How does the Clinical Diagnostics application segment perform in the market?

The Clinical Diagnostics segment is expected to grow to 90.0 USD Billion by 2035. Read More

What are the key end-use sectors in the Gene Sequencing Market?

Pharmaceutical Companies and Academic Research Institutes are significant end-users, with projected valuations of 70.0 USD Billion and 90.0 USD Billion, respectively, by 2035. Read More

What product categories are included in the market?

The market includes Reagents, Instruments, Consumables, and Software, with Instruments expected to reach 70.0 USD Billion by 2035. Read More

Who are the leading players in the market?

Key players include Illumina, Thermo Fisher Scientific, and BGI Genomics, among others. Read More

What is the expected growth of the Third Generation Sequencing technology segment?

The Third Generation Sequencing segment is projected to grow to 50.0 USD Billion by 2035. Read More

How does the Agricultural Biotechnology application segment contribute to the market?

The Agricultural Biotechnology segment is expected to reach 35.13 USD Billion by 2035. Read More

Gene Sequencing Market

Gene Sequencing Market Research Report By Technology (Next Generation Sequencing, Sanger Sequencing, Third Generation Sequencing, Whole Genome Sequencing), By Application (Research, Clinical Diagnostics, Pharmacogenomics, Agricultural Biotechnology), By End Use (Pharmaceutical Companies, Academic and Research Institutes, Hospitals and Clinical Laboratories), By Product (Reagents, Instruments, Consumables, Software) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

22.0%

2024 Market Size

$ 24.7 Billion

2035 Market Size

$ 220.13 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/20243-HCR | Pages: 128 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Technology (USD Billion) | |
  1. 4.1.1 Next Generation Sequencing | |
  2. 4.1.2 Sanger Sequencing | |
  3. 4.1.3 Third Generation Sequencing | |
  4. 4.1.4 Whole Genome Sequencing |
2. 4.2 Healthcare, BY Application (USD Billion) | |
  1. 4.2.1 Research | |
  2. 4.2.2 Clinical Diagnostics | |
  3. 4.2.3 Pharmacogenomics | |
  4. 4.2.4 Agricultural Biotechnology |
3. 4.3 Healthcare, BY End Use (USD Billion) | |
  1. 4.3.1 Pharmaceutical Companies | |
  2. 4.3.2 Academic and Research Institutes | |
  3. 4.3.3 Hospitals and Clinical Laboratories |
4. 4.4 Healthcare, BY Product (USD Billion) | |
  1. 4.4.1 Reagents | |
  2. 4.4.2 Instruments | |
  3. 4.4.3 Consumables | |
  4. 4.4.4 Software |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Illumina (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Thermo Fisher Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 BGI Genomics (CN) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Pacific Biosciences (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Oxford Nanopore Technologies (GB) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Roche Sequencing (CH) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Agilent Technologies (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Qiagen (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Genomatix (DE) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY TECHNOLOGY |
7. 6.4 US MARKET ANALYSIS BY APPLICATION |
8. 6.5 US MARKET ANALYSIS BY END USE |
9. 6.6 US MARKET ANALYSIS BY PRODUCT |
10. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
12. 6.9 CANADA MARKET ANALYSIS BY END USE |
13. 6.10 CANADA MARKET ANALYSIS BY PRODUCT |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
16. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION |
17. 6.14 GERMANY MARKET ANALYSIS BY END USE |
18. 6.15 GERMANY MARKET ANALYSIS BY PRODUCT |
19. 6.16 UK MARKET ANALYSIS BY TECHNOLOGY |
20. 6.17 UK MARKET ANALYSIS BY APPLICATION |
21. 6.18 UK MARKET ANALYSIS BY END USE |
22. 6.19 UK MARKET ANALYSIS BY PRODUCT |
23. 6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
24. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION |
25. 6.22 FRANCE MARKET ANALYSIS BY END USE |
26. 6.23 FRANCE MARKET ANALYSIS BY PRODUCT |
27. 6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
28. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION |
29. 6.26 RUSSIA MARKET ANALYSIS BY END USE |
30. 6.27 RUSSIA MARKET ANALYSIS BY PRODUCT |
31. 6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY |
32. 6.29 ITALY MARKET ANALYSIS BY APPLICATION |
33. 6.30 ITALY MARKET ANALYSIS BY END USE |
34. 6.31 ITALY MARKET ANALYSIS BY PRODUCT |
35. 6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
36. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION |
37. 6.34 SPAIN MARKET ANALYSIS BY END USE |
38. 6.35 SPAIN MARKET ANALYSIS BY PRODUCT |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PRODUCT |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY |
45. 6.42 CHINA MARKET ANALYSIS BY APPLICATION |
46. 6.43 CHINA MARKET ANALYSIS BY END USE |
47. 6.44 CHINA MARKET ANALYSIS BY PRODUCT |
48. 6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY |
49. 6.46 INDIA MARKET ANALYSIS BY APPLICATION |
50. 6.47 INDIA MARKET ANALYSIS BY END USE |
51. 6.48 INDIA MARKET ANALYSIS BY PRODUCT |
52. 6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
53. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION |
54. 6.51 JAPAN MARKET ANALYSIS BY END USE |
55. 6.52 JAPAN MARKET ANALYSIS BY PRODUCT |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PRODUCT |
60. 6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
61. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END USE |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PRODUCT |
64. 6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
65. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION |
66. 6.63 THAILAND MARKET ANALYSIS BY END USE |
67. 6.64 THAILAND MARKET ANALYSIS BY PRODUCT |
68. 6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
69. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION |
70. 6.67 INDONESIA MARKET ANALYSIS BY END USE |
71. 6.68 INDONESIA MARKET ANALYSIS BY PRODUCT |
72. 6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
73. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END USE |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PRODUCT |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
78. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION |
79. 6.76 BRAZIL MARKET ANALYSIS BY END USE |
80. 6.77 BRAZIL MARKET ANALYSIS BY PRODUCT |
81. 6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
82. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION |
83. 6.80 MEXICO MARKET ANALYSIS BY END USE |
84. 6.81 MEXICO MARKET ANALYSIS BY PRODUCT |
85. 6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
86. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END USE |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PRODUCT |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT |
102. 6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
103. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END USE |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PRODUCT |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PRODUCT, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PRODUCT, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PRODUCT, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PRODUCT, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PRODUCT, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PRODUCT, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PRODUCT, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PRODUCT, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PRODUCT, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PRODUCT, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PRODUCT, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PRODUCT, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PRODUCT, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PRODUCT, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PRODUCT, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PRODUCT, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PRODUCT, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PRODUCT, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PRODUCT, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PRODUCT, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PRODUCT, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PRODUCT, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PRODUCT, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PRODUCT, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PRODUCT, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PRODUCT, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PRODUCT, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USE, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PRODUCT, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Gene Sequencing Market Segmentation

Gene Sequencing Market By Technology (USD Billion, 2025-2035)

Next Generation Sequencing
Sanger Sequencing
Third Generation Sequencing
Whole Genome Sequencing

Gene Sequencing Market By Application (USD Billion, 2025-2035)

Research
Clinical Diagnostics
Pharmacogenomics
Agricultural Biotechnology

Gene Sequencing Market By End Use (USD Billion, 2025-2035)

Gene Sequencing Market Companies
Academic and Research Institutes
Hospitals and Clinical Laboratories

Gene Sequencing Market By Product (USD Billion, 2025-2035)

Reagents
Instruments
Consumables
Software

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”